Abstract:Deployment of a Memotherm colonic stent (Bard, Angiomed, Karlsruhe, Germany) across anastomotic strictures, following anterior resection, is described in three patients. Two patients presented with symptoms of colonic obstruction. Two of the patients had previously undergone unsuccessful balloon dilatation of the stricture. In the third, in addition to the anastomotic stricture, there was local tumor recurrence. Initially, stenting provided effective relief of symptoms. However, in all three patients, fracture… Show more
“…Of nine patients who had long-term follow-up (mean follow-up, 19 months), prolonged luminal patency was 11 Crohn's disease Not reported 5 months >4.5 years 12 11 Crohn's disease Covered Z-stent 10 months >3 years 13 17 Crohn's disease Wallstent (Operation 3 weeks after procedure) 14 10 Diverticular disease Wallstent 22 mm No migration (operation 6 days after procedure) 15 18 Diverticular disease Wallstent 20 mm Migration Not available 16 18 Diverticular disease Wallstent 18 mm Migration Not available 17 19 Radiation colitis Wallstent 16 mm 3 weeks >11 months 18 20 Radiation colitis Wallstent 20 mm No migration >4 months 19 21 Granulation Wallstent 22 mm No migration >1 year 20 22 Not available Choo stent Within 3 weeks Not available obtained despite frequent stent migration. Although Odurny 16 questioned the long-term efficacy of stenting in benign strictures, this intervention seemed to provide longer relief of symptoms than balloon dilation and prevented the need for invasive surgery. Further prospective studies examining the use of stents for benign disease will need to address the issue of randomization and suitable controls such as diverting stoma and balloon dilation in patients with benign disease unsuitable for surgery.…”
Section: Discussionmentioning
confidence: 94%
“…To our knowledge, after performing a detailed literature search, only 20 patients from different case series or individual case reports have been reported to have undergone stent insertion for benign obstruction. [10][11][12][13][14][15][16][17][18][19][20][21][22] The indications and outcomes are shown in Table 2. Some of these patients had repeated sessions of balloon dilation before stent insertion but failed to maintain luminal patency.…”
Stent insertion provided an effective outcome in patients with malignant colonic obstruction as a palliative and preoperative therapy. Although a relatively high migration rate was observed in patients with benign strictures, stenting was still effective in providing luminal patency (median follow-up, 7.5 months). Stenting should be considered as a first-line treatment for malignant strictures and as a potential therapy for selected benign strictures.
“…Of nine patients who had long-term follow-up (mean follow-up, 19 months), prolonged luminal patency was 11 Crohn's disease Not reported 5 months >4.5 years 12 11 Crohn's disease Covered Z-stent 10 months >3 years 13 17 Crohn's disease Wallstent (Operation 3 weeks after procedure) 14 10 Diverticular disease Wallstent 22 mm No migration (operation 6 days after procedure) 15 18 Diverticular disease Wallstent 20 mm Migration Not available 16 18 Diverticular disease Wallstent 18 mm Migration Not available 17 19 Radiation colitis Wallstent 16 mm 3 weeks >11 months 18 20 Radiation colitis Wallstent 20 mm No migration >4 months 19 21 Granulation Wallstent 22 mm No migration >1 year 20 22 Not available Choo stent Within 3 weeks Not available obtained despite frequent stent migration. Although Odurny 16 questioned the long-term efficacy of stenting in benign strictures, this intervention seemed to provide longer relief of symptoms than balloon dilation and prevented the need for invasive surgery. Further prospective studies examining the use of stents for benign disease will need to address the issue of randomization and suitable controls such as diverting stoma and balloon dilation in patients with benign disease unsuitable for surgery.…”
Section: Discussionmentioning
confidence: 94%
“…To our knowledge, after performing a detailed literature search, only 20 patients from different case series or individual case reports have been reported to have undergone stent insertion for benign obstruction. [10][11][12][13][14][15][16][17][18][19][20][21][22] The indications and outcomes are shown in Table 2. Some of these patients had repeated sessions of balloon dilation before stent insertion but failed to maintain luminal patency.…”
Stent insertion provided an effective outcome in patients with malignant colonic obstruction as a palliative and preoperative therapy. Although a relatively high migration rate was observed in patients with benign strictures, stenting was still effective in providing luminal patency (median follow-up, 7.5 months). Stenting should be considered as a first-line treatment for malignant strictures and as a potential therapy for selected benign strictures.
“…Even though some authors report that migration occurs only after successful stricture dilation [Vanbiervliet et al 2013], the majority of experts concur with the fact that migration in most cases results in treatment failure requiring additional endoscopic procedures. Moreover, cases of obstruction due to granulation tissue overgrowth at the edge of the stent, mucosal erosion and stent fracture have been described [Odurny, 2001].…”
Background: Self-expandable metal stent (SEMS) placement is a minimally invasive treatment for palliation of malignant colorectal strictures and as a bridge to surgery. However, the use of SEMS for benign colorectal diseases is controversial. The purpose of this retrospective study is to evaluate the efficacy and safety of fully covered SEMS (FCSEMS) placement in postsurgical colorectal diseases. Methods: From 2008 to 2014, 29 patients with 32 FCSEMS deployment procedures were evaluated. The indications for stent placement were: 17 anastomotic strictures (3/17 presented complete closure of the anastomosis); four anastomotic leaks; seven strictures associated with anastomotic leak; and one rectum-vagina fistula. Results: Clinical success was achieved in 18 out of 29 patients (62.1%) being symptom-free at an average of 19 months. In the remaining 11 patients (37.9%), a different treatment was needed: four patients required multiple endoscopic dilations, 4 patients colostomy confection, one patient definitive ileostomy and three patients revisional surgery. The FCSEMS were kept in place for a mean period of 34 (range: 6-65) days. Major complications occurred in 12 out of 29 patients (41.4%) and consisted of stent migration. Minor complications included two cases of transient fever, eight cases of abdominal or rectal pain, and one case of tenesmus. Conclusion: FCSEMS are considered a possible therapeutic option for treatment of postsurgical strictures and leaks. However, their efficacy in guaranteeing long-term anastomotic patency and leak closure is moderate. A major complication is migration. The use of FCSEMS for colonic postsurgical pathologies should be carefully evaluated for each patient.
“…Stents placed across benign strictures may be particularly prone to fracture [7,12]. The unique features that predispose to stent fracture include healing by fibrosis, long-term constant compressive forces and acute angulation; a more flexible stent may be less prone to this complication.…”
A 66-year-old man underwent an anterior resection for carcinoma at the rectosigmoid junction. Three months later, a tight stricture developed proximal to the anastomosis. This was treated with a self-expanding metallic stent. Over the next few months, the stent fractured and a fistula developed between the site of anastomic stricture and the distal ileum; the stent had to be removed. This, to our knowledge, is the first report of a coloenteric fistula developing after insertion of a metallic stent to treat a benign postoperative anastomotic stricture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.